China News Service, February 6th. According to the website of the State Drug Administration, on February 5, the State Drug Administration conditionally approved the new coronavirus inactivated vaccine (Vero cell) of Beijing Kexing Zhongwei Biotechnology Co., Ltd. Registration application.
The vaccine is suitable for preventing the disease caused by the new coronavirus infection (COVID-19).
Data map: On January 6, a reporter from China News Service went to Beijing Kexing Zhongwei Biotechnology Co., Ltd. in Daxing District, Beijing, to visit the production line of the new coronavirus inactivated vaccine.
The picture shows the staff showing the vaccine in vials.
Photo by China News Agency reporter Hou Yu
According to the relevant provisions of the "Vaccine Administration Law" and "Drug Administration Law", the State Food and Drug Administration conducts emergency review and approval in accordance with the special drug approval procedures, and approves the listing application with conditions.
The State Food and Drug Administration requires the holder of the vaccine marketing license to continue to carry out relevant research work, complete the conditional requirements, and submit follow-up research results in a timely manner.